Treatment Adherence to Oral Direct‐Acting Antiviral Agents in Hepatitis C Infection

Jamsari Khalid; Jieni Li; Rajender R. Aparasu

doi:10.1002/phar.70126

April 7, 2026Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy

Treatment Adherence to Oral Direct‐Acting Antiviral Agents in Hepatitis C Infection

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to assess adherence levels to DAA therapy in hepatitis C and identify factors affecting adherence.
Analysis of treatment adherence data for DAA in hepatitis C
Identification of clinical and non-clinical factors affecting adherence
Development of potential interventions based on findings.
Overall adherence to DAA therapy was found to be high among HCV patients.
Several clinical and non-clinical factors contribute to non-adherence.
Findings suggest a need for targeted interventions to improve adherence.

Implication

Analysis shows factors influencing adherence to antiviral treatment in hepatitis C, suggesting targeted interventions may help.

Abstract

Overall adherence to DAA therapy was high in HCV; however, several clinical and non-clinical factors were associated with non-adherence. Findings from this study can inform the development of targeted interventions to optimize DAA adherence in HCV.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Khalid et al. (2026) studied this question.

synapsesocial.com/papers/69d895be6c1944d70ce06d34 https://doi.org/10.1002/phar.70126

View Full Paper

Ask AI

Bookmark

Share

Treatment Adherence to Oral Direct‐Acting Antiviral Agents in Hepatitis C Infection

Key Points

Implication

Abstract

Discussion

Cite This Study

Treatment Adherence to Oral Direct‐Acting Antiviral Agents in Hepatitis C Infection

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading